Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents

The previously reported as well as newly synthesized derivatives of the 1-oxa-9-azaspiro[5.5]undecane were employed in the synthesis of thirty-six derivatives of ciprofloxacin using commercially available 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and the literature...

Full description

Bibliographic Details
Main Authors: Alexei Lukin, Mikhail Chudinov, Tatiana Vedekhina, Elizaveta Rogacheva, Lyudmila Kraeva, Olga Bakulina, Mikhail Krasavin
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/15/4864
_version_ 1797412912873078784
author Alexei Lukin
Mikhail Chudinov
Tatiana Vedekhina
Elizaveta Rogacheva
Lyudmila Kraeva
Olga Bakulina
Mikhail Krasavin
author_facet Alexei Lukin
Mikhail Chudinov
Tatiana Vedekhina
Elizaveta Rogacheva
Lyudmila Kraeva
Olga Bakulina
Mikhail Krasavin
author_sort Alexei Lukin
collection DOAJ
description The previously reported as well as newly synthesized derivatives of the 1-oxa-9-azaspiro[5.5]undecane were employed in the synthesis of thirty-six derivatives of ciprofloxacin using commercially available 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and the literature protocol involving the preparation of boron chelate complex to facilitate nucleophilic aromatic substitution. All new fluoroquinolone derivatives were tested against two gram-positive as well as three gram-negative strains of bacteria. With the activity spectrum of the new derivatives being substantially narrower than that of ciprofloxacin, compounds were distinctly active against two of the five strains: gram-negative <i>Acinetobacter baumannii</i> 987<sup>®</sup> and gram-positive <i>Bacillus cereus</i> 138<sup>®</sup>. Towards these two strains, a large group of compounds displayed equal or higher potency than ciprofloxacin.
first_indexed 2024-03-09T05:10:07Z
format Article
id doaj.art-7104e93f92364046ae19f85c2d4ccfe3
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T05:10:07Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-7104e93f92364046ae19f85c2d4ccfe32023-12-03T12:50:10ZengMDPI AGMolecules1420-30492022-07-012715486410.3390/molecules27154864Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial AgentsAlexei Lukin0Mikhail Chudinov1Tatiana Vedekhina2Elizaveta Rogacheva3Lyudmila Kraeva4Olga Bakulina5Mikhail Krasavin6Lomonosov Institute of Fine Chemical Technologies, MIREA—Russian Technological University, 119454 Moscow, RussiaLomonosov Institute of Fine Chemical Technologies, MIREA—Russian Technological University, 119454 Moscow, RussiaFederal Research and Clinical Center of Physico-Chemical Medicine, 1a Malaya Pirogovskaya Street, 119435 Moscow, RussiaPasteur Institute of Epidemiology and Microbiology, 14 Mira Street, 197101 Saint Petersburg, RussiaPasteur Institute of Epidemiology and Microbiology, 14 Mira Street, 197101 Saint Petersburg, RussiaSaint Petersburg State University, 26 Universitetskii Prospect, 198504 Peterhof, RussiaSaint Petersburg State University, 26 Universitetskii Prospect, 198504 Peterhof, RussiaThe previously reported as well as newly synthesized derivatives of the 1-oxa-9-azaspiro[5.5]undecane were employed in the synthesis of thirty-six derivatives of ciprofloxacin using commercially available 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and the literature protocol involving the preparation of boron chelate complex to facilitate nucleophilic aromatic substitution. All new fluoroquinolone derivatives were tested against two gram-positive as well as three gram-negative strains of bacteria. With the activity spectrum of the new derivatives being substantially narrower than that of ciprofloxacin, compounds were distinctly active against two of the five strains: gram-negative <i>Acinetobacter baumannii</i> 987<sup>®</sup> and gram-positive <i>Bacillus cereus</i> 138<sup>®</sup>. Towards these two strains, a large group of compounds displayed equal or higher potency than ciprofloxacin.https://www.mdpi.com/1420-3049/27/15/4864antibacterialciprofloxacinaromatic nucleophilic substitutionspirocyclicpiperidines
spellingShingle Alexei Lukin
Mikhail Chudinov
Tatiana Vedekhina
Elizaveta Rogacheva
Lyudmila Kraeva
Olga Bakulina
Mikhail Krasavin
Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents
Molecules
antibacterial
ciprofloxacin
aromatic nucleophilic substitution
spirocyclic
piperidines
title Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents
title_full Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents
title_fullStr Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents
title_full_unstemmed Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents
title_short Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents
title_sort exploration of spirocyclic derivatives of ciprofloxacin as antibacterial agents
topic antibacterial
ciprofloxacin
aromatic nucleophilic substitution
spirocyclic
piperidines
url https://www.mdpi.com/1420-3049/27/15/4864
work_keys_str_mv AT alexeilukin explorationofspirocyclicderivativesofciprofloxacinasantibacterialagents
AT mikhailchudinov explorationofspirocyclicderivativesofciprofloxacinasantibacterialagents
AT tatianavedekhina explorationofspirocyclicderivativesofciprofloxacinasantibacterialagents
AT elizavetarogacheva explorationofspirocyclicderivativesofciprofloxacinasantibacterialagents
AT lyudmilakraeva explorationofspirocyclicderivativesofciprofloxacinasantibacterialagents
AT olgabakulina explorationofspirocyclicderivativesofciprofloxacinasantibacterialagents
AT mikhailkrasavin explorationofspirocyclicderivativesofciprofloxacinasantibacterialagents